Objective: The aim of this study was the development of an accurate and quantitative pyrosequence (PSQ) method for paternal RHD zygosity detection to help risk management of hemolytic disease of the fetus and newborn (HDFN).

Methods: Blood samples from 96 individuals were genotyped for RHD zygosity using pyrosequencing assay. To validate the accuracy of pyrosequencing results, all the samples were then detected by the mismatch polymerase chain reaction with sequence-specific primers (PCR-SSP) method and Sanger DNA sequencing. Serological tests were performed to assess RhD phenotypes.

Results: Serological results revealed that 36 cases were RhD-positive and 60 cases were RhD-negative. The concordance rate between pyrosequencing assay and mismatch PCR-SSP assay was 94.8% (91/96). There were 5 discordant results between pyrosequencing and the mismatch PCR-SSP assay. Sanger sequencing confirmed that the pyrosequencing assay correctly assigned zygosity for the 5 samples.

Conclusion: This DNA pyrosequencing method accurately detect RHD zygosity and will help risk management of pregnancies that are at risk of HDFN.

Download full-text PDF

Source
http://dx.doi.org/10.1093/labmed/lmad051DOI Listing

Publication Analysis

Top Keywords

rhd zygosity
16
pyrosequencing assay
12
hemolytic disease
8
disease fetus
8
fetus newborn
8
help risk
8
risk management
8
mismatch pcr-ssp
8
pcr-ssp assay
8
pyrosequencing
6

Similar Publications

[ Genotyping Characteristics of RhD-Negative Blood Donors in Wuhu Area].

Zhongguo Shi Yan Xue Ye Xue Za Zhi

October 2024

Inspection College, Wannan Medical College, Wuhu 241002, Anhui Province, China.

Objective: To investigate the molecular mechanism and distribution characteristics of RhD negative phenotypes in Han population of blood donors in Wuhu city.

Methods: A total of 210 RhD samples from August 2021 to August 2022 were screened by serological test and collected from Wuhu Central Blood Station for the voluntary blood donor population. Exons 1 and 10 of the gene were amplificated by PCR to determine whether the samples had the gene.

View Article and Find Full Text PDF

Objective: To explore the Rh genotype for a female with RhD(-) blood type and its molecular basis.

Methods: A 26-year-old female who had attended the outpatient clinic of the First Affiliated Hospital of Zhengzhou University in August 2019 was selected as the study subject. Peripheral blood samples were collected from the proband and her parents for Rh phenotyping with gel card method.

View Article and Find Full Text PDF

Background: The gene is one of the most complex blood group genes. The molecular background of the gene in RhD-negative and RhD-positive individuals varies within and among different populations. Knowing the molecular basis of the gene in a specific population is required to establish effective genotyping methods.

View Article and Find Full Text PDF

Introduction: With over 360 blood group antigens in systems recognized, there are antigens, such as RhD, which demonstrate a quantitative reduction in antigen expression due to nucleotide variants in the non-coding region of the gene that result in aberrant splicing or a regulatory mechanism. This study aimed to evaluate bioinformatically predicted GATA1-binding regulatory motifs in the gene for samples presenting with weak or apparently negative RhD antigen expression but showing normal exons.

Methods: Publicly available open chromatin region data were overlayed with GATA1 motif candidates in .

View Article and Find Full Text PDF

Rh phenotype matching reduces but does not eliminate alloimmunization in patients with sickle cell disease (SCD) due to RH genetic diversity that is not distinguishable by serological typing. RH genotype matching can potentially mitigate Rh alloimmunization but comprehensive and accessible genotyping methods are needed. We developed RHtyper as an automated algorithm to predict RH genotypes using whole-genome sequencing (WGS) data with high accuracy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!